Results 201 to 210 of about 22,512 (233)

Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE. [PDF]

open access: yesDrugs Context
Tran NT   +6 more
europepmc   +1 more source

Crohn's disease and ulcerative colitis in β-thalassemia major: A report of two cases and a brief review of the literature. [PDF]

open access: yesMed Int (Lond)
Amin TA   +10 more
europepmc   +1 more source

A review of genetic modification for ex vivo cellular therapies

open access: yes
Transfusion, Volume 66, Issue S2, Page S45-S57, September 2026.
Anh Dinh, Nan Zhang, David Stroncek
wiley   +1 more source

HbA1c-based diagnosis of type 2 diabetes and complication risk are distorted in British south Asians due to HbE thalassaemia trait

open access: yes
Hodgson S   +12 more
europepmc   +1 more source

The Splenectomy Paradox in Thalassemia: Reduced Transfusion Requirements vs. Accelerated Hepatic Fibrogenesis. [PDF]

open access: yesMediterr J Hematol Infect Dis
Padeniya P   +5 more
europepmc   +1 more source

Protecting against genetic discrimination requires more than a law. [PDF]

open access: yesLancet Reg Health West Pac
The Lancet Regional Health-Western Pacific.
europepmc   +1 more source

Outcomes with luspatercept in patients with β-thalassemia: a systematic review and meta-analysis. [PDF]

open access: yesAnn Hematol
Babiker N   +9 more
europepmc   +1 more source

Evaluating compliance with restrictive blood transfusion practices: A 5-year study from a Greek tertiary hospital. [PDF]

open access: yesVox Sang
Nikolopoulos GK   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy